Norges Bank Myovant Sciences Ltd. Transaction History

Norges Bank

  • $716 Trillion
  • Q3 2024

Shares

42 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
SELL
N/A
-342,873 Closed
0 $0
Q2 2023

Aug 14, 2023
SELL
N/A
-342,873 Closed
0 $0
Q4 2022

Feb 14, 2023
BUY
$24.03 - $27.02 $9.03 Million - $10.2 Million
375,781 New
375,781 $10.1 Million
Q3 2022

Nov 13, 2023
BUY
$11.6 - $20.44 $3.98 Million - $7.01 Million
342,873 New
342,873 $6.16 Million
Q2 2022

Aug 14, 2023
BUY
$7.78 - $14.69 $2.67 Million - $5.04 Million
342,873 New
342,873 $4.26 Million
Q1 2022

May 12, 2023
SELL
$11.38 - $16.4 $287,345 - $414,099
-25,250 Reduced 6.72%
350,531 $4.67 Million
Q1 2022

May 09, 2022
SELL
$11.38 - $16.4 $4.72 Million - $6.81 Million
-414,986 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$14.31 - $23.87 $5.94 Million - $9.91 Million
414,986 New
414,986 $6.46 Million
Q3 2021

Nov 14, 2022
BUY
$18.94 - $26.99 $24.1 Million - $34.3 Million
1,271,756 New
1,271,756 $28.5 Million
Q3 2021

Nov 05, 2021
SELL
$18.94 - $26.99 $23.9 Million - $34 Million
-1,260,670 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$17.07 - $24.56 $21.5 Million - $31 Million
1,260,670 New
1,260,670 $28.7 Million
Q2 2021

Aug 10, 2021
SELL
$17.07 - $24.56 $21.1 Million - $30.4 Million
-1,238,655 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$20.46 - $25.18 $25.3 Million - $31.2 Million
1,238,655 New
1,238,655 $25.5 Million
Q1 2021

May 07, 2021
SELL
$20.46 - $25.18 $31.3 Million - $38.5 Million
-1,527,540 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$13.8 - $27.62 $21.1 Million - $42.2 Million
1,527,540 New
1,527,540 $42.2 Million
Q4 2020

Feb 10, 2021
SELL
$13.8 - $27.62 $21.1 Million - $42.2 Million
-1,527,540 Closed
0 $0
Q3 2020

Nov 12, 2021
BUY
$14.05 - $22.6 $21.5 Million - $34.5 Million
1,527,540 New
1,527,540 $21.5 Million
Q3 2020

Nov 10, 2020
SELL
$14.05 - $22.6 $9.5 Million - $15.3 Million
-676,443 Closed
0 $0
Q2 2020

Aug 13, 2021
BUY
$7.34 - $20.84 $4.97 Million - $14.1 Million
676,443 New
676,443 $13.9 Million
Q2 2020

Aug 07, 2020
SELL
$7.34 - $20.84 $4.97 Million - $14.1 Million
-676,443 Closed
0 $0
Q1 2020

May 07, 2021
BUY
$6.55 - $14.76 $4.43 Million - $9.98 Million
676,443 New
676,443 $5.11 Million
Q1 2020

May 08, 2020
SELL
$6.55 - $14.76 $4.43 Million - $9.98 Million
-676,443 Closed
0 $0
Q4 2019

Mar 03, 2020
BUY
$4.2 - $19.21 $2.84 Million - $13 Million
676,443 New
676,443 $10.5 Million
Q4 2019

Feb 12, 2020
SELL
$4.2 - $19.21 $5.67 Million - $25.9 Million
-1,350,000 Closed
0 $0
Q3 2019

Nov 13, 2020
BUY
$5.19 - $9.46 $7.01 Million - $12.8 Million
1,350,000 New
1,350,000 $7.02 Million
Q3 2019

Nov 08, 2019
SELL
$5.19 - $9.46 $7.01 Million - $12.8 Million
-1,350,000 Closed
0 $0
Q2 2019

Aug 13, 2020
BUY
$8.69 - $25.0 $11.7 Million - $33.8 Million
1,350,000 New
1,350,000 $12.2 Million
Q2 2019

Aug 09, 2019
SELL
$8.69 - $25.0 $6.52 Million - $18.8 Million
-750,000 Closed
0 $0
Q4 2018

Mar 04, 2019
BUY
$15.01 - $25.2 $11.3 Million - $18.9 Million
750,000 New
750,000 $12.3 Million
Q4 2018

Feb 08, 2019
SELL
$15.01 - $25.2 $11.3 Million - $18.9 Million
-750,000 Closed
0 $0
Q3 2018

Nov 12, 2019
BUY
$19.33 - $26.78 $14.5 Million - $20.1 Million
750,000 New
750,000 $19.9 Million
Q3 2018

Nov 09, 2018
SELL
$19.33 - $26.78 $11.6 Million - $16.1 Million
-600,000 Closed
0 $0
Q2 2018

Aug 12, 2019
BUY
$19.2 - $25.14 $11.5 Million - $15.1 Million
600,000 New
600,000 $13.7 Million
Q2 2018

Jul 23, 2018
SELL
$19.2 - $25.14 $11.5 Million - $15.1 Million
-600,000 Closed
0 $0
Q1 2018

May 15, 2019
BUY
$12.46 - $21.32 $7.48 Million - $12.8 Million
600,000 New
600,000 $12.8 Million
Q1 2018

May 09, 2018
SELL
$12.46 - $21.32 $7.48 Million - $12.8 Million
-600,000 Closed
0 $0
Q4 2017

Mar 05, 2018
BUY
$11.37 - $16.4 $6.82 Million - $9.84 Million
600,000 New
600,000 $7.58 Million
Q4 2017

Feb 09, 2018
SELL
$11.37 - $16.4 $6.82 Million - $9.84 Million
-600,000 Closed
0 $0
Q3 2017

Nov 13, 2018
BUY
$9.93 - $15.47 $5.96 Million - $9.28 Million
600,000 New
600,000 $9.28 Million
Q3 2017

Nov 07, 2017
SELL
$9.93 - $15.47 $5.96 Million - $9.28 Million
-600,000 Closed
0 $0
Q2 2017

Jul 24, 2018
SELL
N/A
-21,719 Reduced 3.49%
600,000 $7.02 Million
Q1 2017

May 11, 2018
BUY
N/A
621,719
621,719 $7.3 Million

Others Institutions Holding MYOV

# of Institutions
6
Shares Held
61.3K
Call Options Held
0
Put Options Held
0
View Full List

About Myovant Sciences Ltd.

MYOV Quotes by TradingView
  • Ticker MYOV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 96,802,800
  • Description
  • Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...
More about MYOV
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email